Patents vs. Patients: Prioritizing Equitable Access Over Intellectual Property Rights

Health is the foundation of human well-being and the cornerstone of a thriving society. Good health is not merely a privilege—it is a fundamental right that underpins all other rights and freedoms. However, this right is increasingly jeopardized by patents and profit-driven pharmaceutical policies. Life-saving medications, restricted by patents and monopolies, are often accessible only to those who can afford their exorbitant prices. Intellectual property (IP) protections, initially intended to drive innovation, have instead turned life-saving drugs into luxury products, priced out of reach for the average person. Ensuring equitable access to pharmaceuticals is key to addressing deep-rooted inequalities and reducing preventable suffering. This paper explores the current public health crisis, examines the impact of intellectual property rights, and highlights the urgent need for reform, ultimately advocating for a healthcare system that prioritizes people over profit.